About: Cancer Center Recommendations to Mitigate COVID-19 Impact in Patients With Cancer: Low-Resource Settings Version

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cancer Center Recommendations to Mitigate COVID-19 Impact in Patients With Cancer: Low-Resource Settings Version Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Cancer Center Recommendations to Mitigate COVID-19 Impact in Patients With Cancer: Low-Resource Settings Version
Creator	Cardona, Andres Perez, Carlos Pino, Luis
source	Medline; PMC
abstract	covid:6163faf31b5137cf6adbfe2d878f9b3cb73ece2a#abstract
has issue date	2020-04-13(xsd:dateTime)
bibo:doi	10.1200/go.20.00093
bibo:pmid	32282234
has license	cc-by
sha1sum (hex)	6163faf31b5137cf6adbfe2d878f9b3cb73ece2a
schema:url	https://doi.org/10.1200/go.20.00093
resource representing a document's title	Cancer Center Recommendations to Mitigate COVID-19 Impact in Patients With Cancer: Low-Resource Settings Version
has PubMed Central identifier	PMC7193779
has PubMed identifier	32282234
schema:publication	JCO Glob Oncol
resource representing a document's body	covid:6163faf31b5137cf6adbfe2d878f9b3cb73ece2a#body_text
is schema:about of	named entity 'Outcomes' named entity 'faster' named entity 'infection' named entity 'RECEIVED' named entity 'CHINESE' named entity 'THESE' named entity 'DETERIORATION' named entity 'patients' named entity 'active' named entity 'risk' named entity 'evolution' named entity 'COVID-19 outbreak' named entity 'clinical characteristics' named entity 'higher risk' named entity 'telemedicine' named entity 'COVID-19' named entity 'prognosis' named entity 'Google Suite' named entity 'population registry' named entity 'soft tissue sarcomas' named entity 'Tumor' named entity 'follow-up' named entity 'pembrolizumab' named entity 'COVID-19' named entity 'clinical characteristics' named entity 'intensive care unit' named entity 'long-term' named entity 'caregiver' named entity 'hormonal therapies' named entity 'older patients' named entity 'surgical treatments' named entity 'health care' named entity 'intravenous' named entity 'nivolumab' named entity 'COVID-19' named entity 'health care' named entity 'denosumab' named entity 'pembrolizumab' named entity 'COVID-19' named entity 'chemotherapy' named entity 'high-grade' named entity 'leukemias' named entity 'immunotherapy' named entity 'infectious disease' named entity 'long-term' named entity 'COVID-19' named entity 'diagnostic tests' named entity 'oncological' named entity 'toxicity' named entity 'palliative care' named entity 'prostate cancer' named entity 'Skype' named entity 'diagnostic process' named entity 'COVID-19' named entity 'cancer center' named entity 'lymphomas' named entity 'health authority' named entity 'body temperature' named entity 'virtual assistance' named entity 'pegfilgrastim' named entity 'bisphosphonates' named entity 'off-label' named entity 'clinical practice' named entity 'RISK' named entity 'COVID-19' named entity 'EVOLUTION' named entity 'OUTCOMES' named entity 'OUTBREAK' covid:arg/6163faf31b5137cf6adbfe2d878f9b3cb73ece2a named entity 'infection' named entity 'ACTIVE TREATMENT' named entity 'HAVE' named entity 'SEVERE' named entity 'CLINICAL CHARACTERISTICS' named entity 'DAYS' named entity 'DEATH' named entity 'ODDS RATIO' named entity 'HIGHER' named entity 'INCLUDING'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software